Skip to content

Search

Showing results for "1"

What constitutes cerebral palsy in the twenty-first century?

The aims of this paper were to (1) define inclusion/exclusion criteria that have been adopted uniformly by surveillance programmes and identify where...

Preparing for school in 2024

It's the new school year and by now your child's school should have a copy of their updated Diabetes Management Plan. Adele Connor, Diabetes in

Diabetes and the new school year

It is important to make sure your school has an up-to-date diabetes management plan now that school has begun.

In other news ....

Diabetes-related news, funding announcements and our latest published research.

PCH takes lead in Diabetes In Schools program

Perth Children’s Hospital will be one of the first hospitals in Australia to deliver critical diabetes training to teachers and school staff as part of a new national Diabetes in Schools program.

Meat matters

Type 1 diabetes patients require about 50 per cent more insulin with a high protein meal then with a low protein meal to maintain a stable blood glucose level, according to new research from the Children’s Diabetes Centre at The Kids Research Institute Australia.

Virtual reality diabetes

When Josh Wulf’s son was diagnosed with Type 1 Diabetes, little did he know that one day he would be helping other T1D families manage the condition.

ENDIA milestone

The ENDIA study — Australia’s largest study into the causes of Type 1 Diabetes— reached a significant milestone when it recruited its 700th patient in Perth.

Six cases of ENPP1 pathogenic variants causing autosomal recessive hypophosphatemic rickets type 2 and generalized arterial calcification of infancy

Autosomal recessive hypophosphatemic rickets type 2 (ARHR2) and generalized arterial calcification of infancy (GACI) occur secondary to biallelic ectonucleotide pyrophosphate/phosphodiesterase 1 (ENPP1) loss-of-function pathogenic variants. GACI is a life-threatening condition, often presenting in the neonatal period with heart failure and hypertension, caused by calcification of the media in large- and medium-sized arteries.

CGM accuracy: Contrasting CE marking with the governmental controls of the USA (FDA) and Australia (TGA): A narrative review

The National Institute for Clinical Excellence updated guidance for continuous glucose monitoring (CGM) in 2022, recommending that CGM be available to all people living with type 1 diabetes. Manufacturers can trade in the UK with Conformité Européenne (CE) marking without an initial national assessment. The regulatory process for CGM CE marking, in contrast to the Food and Drug Administration (FDA) and Australian Therapeutic Goods Administration (TGA) process, is described.